EN
HI
Natco Pharma share price chart
Natco Pharma Share Key Metrics
Volume
2.76 L
Market Cap
15716.89 CR
LTQ@LTP
10@877.50
ATP
882.97
Var Margin
19.13 %
Circuit Range
708.3-1062.4
Delivery %
44.02 %
Value
24.37 CR
ASM/GSM
No
Market Lot
1
Summary
NATCOPHARM stock price is ₹877.5 as of 20 Aug, 2026. The stock intraday movement has stayed between ₹874.55 and ₹895.35, while Natco Pharma share price 52 week high low is ₹789.00 & ₹1226.80.
In terms of trading activity, NATCOPHARM share price has recorded a volume of 2,75,997 shares. The Natco Pharma has a market cap of ₹179109870. The stock’s Average Traded Price (ATP) stands at ₹882.97, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹877.50.
The Natco Pharma upper circuit limit is ₹1062.40 & The Natco Pharma lower circuit limit is ₹708.30, with a Value of ₹24.37 CR. The Delivery Percentage for the day is 44.02%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Natco Pharma Fundamentals
P/E Ratio
13.88
P/B Ratio
1.7
Div. Yield
0.56
Sector P/E
65.06
Sector P/B
3.33
Sec. Div. Yield
0.51
Natco Pharma Resistance and Support
Pivot 895.28
Resistance
First Resistance
907.56
Second Resistance
928.28
Third Resistance
940.56
Support
First Support
874.56
Second Support
862.28
Third Support
841.56
Natco Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 20 2026 | 890.5 | 877.5 | -1.05% | 895.35 | 874.55 |
| Wed Aug 19 2026 | 898.95 | 886.84 | -1.28% | 916 | 883 |
| Tue Aug 18 2026 | 890.59 | 898.34 | 0.96% | 901 | 890 |
Natco Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results & Interim Dividend |
| 2026-05-29 | Audited Results |
| 2026-03-24 | Scheme of Arrangement |
| 2026-02-12 | Quarterly Results & Interim Dividend |
| 2025-11-14 | Quarterly Results & Interim Dividend |
| 2025-08-12 | Quarterly Results & Interim Dividend |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-12 | Quarterly Results & Interim Dividend |
| 2024-08-12 | Quarterly Results & Interim Dividend |
Natco Pharma News
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Natco Pharma officials will engage in an investor meeting with Nuvama Wealth Management and ICICI Securities Limited from August 24-26, 2026. The meeting will take place in Singapore to discuss the company's existing investor presentation.
Aug 19 2026 19:14:03
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Natco Pharma Limited has made available the audio weblink of its earnings conference call for Q1 FY27, which took place on August 14, 2026. This allows investors to access the discussions and insights from the call.
Aug 14 2026 18:59:54
Read More
Natco Pharma Management
| Name | Position |
|---|---|
| Chekuri Venkat Ramesh | Company Secretary & Compliance Officer |
| V C Nannapaneni | Chairman & Managing Director |
Natco Pharma Similar Stocks
Poly Medicure Ltd.
1769.60
-0.70 (0.04%)
Onesource Specialty Pharma Ltd.
1534.50
14.00 (0.92%)
Cohance Lifesciences Ltd.
475.55
28.70 (6.42%)
Concord Biotech Ltd.
1576.70
-10.80 (0.68%)
Alembic Pharmaceuticals Ltd.
814.10
-3.40 (0.42%)
Dr. Agarwal's Health Care Ltd.
503.10
1.25 (0.25%)
Shilpa Medicare Ltd.
820.95
13.20 (1.63%)
Vijaya Diagnostic Centre Ltd.
1498.40
8.40 (0.56%)
Rainbow Children's Medicare Ltd.
1453.50
-8.30 (0.57%)
Natco Pharma FAQs
The Buying Price of Natco Pharma share is 877.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Natco Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Natco Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Natco Pharma shares is 13.88. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Natco Pharma shares is 1.7. Useful to assess the stock's value relative to its book value.
To assess Natco Pharma’s valuation compare Sector P/E, P/B which are 65.06 & 3.33 with sector averages, along with growth rates and financial metrics.
The Market Cap of Natco Pharma is 15716.89 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Natco Pharma share price is 1226.80 & 789.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Natco Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NATCOPHARM
Or Download Choice FinX App
Invest in NATCOPHARM
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade